Lighthouse Pharmaceuticals announces receipt of USD49.2m grant from NIA for LHP588 study

Bio-Thera and STADA expand biosimilars partnership to include tocilizumab

Shilpa Medicare secures approval for NAFLD therapy NorUDCA in India

Remegen's Telitacicept meets Sjogren's syndrome Phase III trial's primary endpoint

PainReform acquires majority stake in LayerBio to advance dropless cataract surgery therapy

Seragon launches Enlivien sleep and longevity optimiser

Insmed's BRINSUPRI (brensocatib) non-cystic fibrosis bronchiectasis treatment approved by US FDA

Fosun Pharma agrees XH-S004 overseas licensing deal

Novartis reports positive Phase III results for ianalumab in Sjögren's disease

Avobis Bio seeks RMAT designation after primary analysis of clinical trial in Crohn's perianal fistulas

CivicaScript to distribute biosimilar for chronic inflammatory conditions

MetaVia collaborates with Syntekabio to explore AI-driven indications for DA-1241

Formation Bio licenses IMIDomics' anti-CD226 autoimmune programme

Vascarta names Dr. Janet Loesberg as fractional chief strategy officer

Hengrui Pharma and GSK to jointly develop up to 12 innovative medicines